ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded

June 1, 2012

NCI Budget for FY 1977 Would Halt New Research

January 23, 1976

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

April 28, 2006

In Brief: Cancer Panel To Meet In Seattle, Houston, Chicago; Wisconsin’s Robert Johnson Dies; Goldin Retires

August 27, 1982

NCI Moves To Suspend Researcher Amid Charges Contractor Made Mortgage And Other Payments

May 4, 1990

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008